Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Strategies to Enhance New CGM Use in Early Childhood (SENCE)

NCT: NCT02912728 · COMPLETED

NCT IDNCT02912728
StatusCOMPLETED
Start Date2017-01-30
Completion2019-06-30
SponsorJaeb Center for Health Research (OTHER)
First posted
Last updated

Brief Summary

The primary objective of this study is to compare the efficacy and safety of CGM alone and CGM combined with a family behavioral intervention with a control group using home blood glucose monitoring (BGM) alone.

Frequently Asked Questions

What is Strategies to Enhance New CGM Use in Early Childhood (SENCE)?

Strategies to Enhance New CGM Use in Early Childhood (SENCE) is a clinical trial registered under NCT02912728. Current status: COMPLETED.

What is the status of NCT02912728?

The current status of NCT02912728 (Strategies to Enhance New CGM Use in Early Childhood (SENCE)) is: COMPLETED.

When did Strategies to Enhance New CGM Use in Early Childhood (SENCE) start?

Strategies to Enhance New CGM Use in Early Childhood (SENCE) started on 2017-01-30.

Related Devices

K241335Eversense 365 Continuous Glucose Monitoring (CGM) SystemSenseonics, Incorporated K152534Medisign MM1000 BT Blood Glucose Monitoring System, Medisign MM1100 BT Blood Glucose Monitoring System, Medisign MM1200 BT Blood Glucose Monitoring System, Smart Diabetes Bluetooth Blood Glucose Monitoring System, Medisign MM 1000 BT MULTI Blood Glucose Monitoring System, Medisign MM 1100 BT MULTI Blood Glucose Monitoring System, Medisign MM 1200 BT MULTI Blood Glucose Monitoring System, Smart Diabetes Bluetooth Pro Blood Glucose Monitoring SystemTianjin Empecs Medical Device Co., Ltd. K171822NuvoMed Wireless Blood Glucose Monitoring System (Model BGM-6/0352)Biotest Medical Corporation K182428GlucoLeader Enhance Blood Glucose Monitoring SystemHmd Biomedical, Inc. K212248GlucoLeader Enhance 2 Blood Glucose Monitoring SystemHmd Biomedical, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑